This protocol addresses confirmed Giardiasis presenting in a patient who is pregnant and in the first trimester. The concurrent pregnancy creates specific constraints on antiparasitic selection that require a tailored therapeutic approach distinct from the standard adult regimen.
Active pregnancy in the first trimester is the defining clinical factor here. When treatment of Giardiasis is required during this period, the choice of antiparasitic agent must account for fetal safety. Not all standard antiparasitic options are appropriate in the first trimester.
If treatment can be safely deferred, that option should be evaluated; however, when intervention is necessary, agent selection follows trimester-specific guidance.
When treatment is required in the first trimester, a specific antiparasitic agent is recommended as the preferred option. A commonly used antiparasitic for Giardiasis in non-pregnant adults is not recommended during the first trimester.
In pregnancy, if treatment is required, paromomycin should be tried in the first trimester and paromomycin or metronidazole should be used in the second and third trimesters.
Nevertheless, paromomycin has been used successfully to eradicate G. lamblia infection in the gravid patient and is an important agent to consider during the first trimester, when metronidazole should not be used.
DOI: 10.1128/CMR.14.1.114–128.2001
View source ↗